VEA
CERE
Virtus ETF Advisers’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,895
| Closed | -$63.2K | – | 467 |
|
|
2023
Q3 | $63.2K | Sell |
2,895
-287
| -9% | -$6.27K | 0.04% | 398 |
|
|
2023
Q2 | $101K | Sell |
3,182
-578
| -15% | -$18.4K | 0.06% | 375 |
|
|
2023
Q1 | $91.7K | Sell |
3,760
-1,451
| -28% | -$35.4K | 0.05% | 356 |
|
|
2022
Q4 | $164K | Buy |
5,211
+916
| +21% | +$28.9K | 0.09% | 328 |
|
|
2022
Q3 | $121K | Buy |
4,295
+36
| +0.8% | +$1.01K | 0.05% | 397 |
|
|
2022
Q2 | $113K | Sell |
4,259
-957
| -18% | -$25.4K | 0.04% | 400 |
|
|
2022
Q1 | $183K | Sell |
5,216
-309
| -6% | -$10.8K | 0.08% | 204 |
|
|
2021
Q4 | $179K | Sell |
5,525
-10,142
| -65% | -$329K | 0.07% | 251 |
|
|
2021
Q3 | $462K | Sell |
15,667
-817
| -5% | -$24.1K | 0.2% | 152 |
|
|
2021
Q2 | $422K | Buy |
+16,484
| New | +$422K | 0.17% | 188 |
|